Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 2 1

Status

Terminated 3Unknown 2Completed 2Active not recruiting 2Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 3INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 1

Conditions

Lymphedema 1Breast Neoplasms 1Adenoma 1

Interventions

Cyclophosphamide 241Radiotherapy 217Gemcitabine 187Cisplatin 185Carboplatin 182Docetaxel 166Bevacizumab 166Paclitaxel 144Capecitabine 142Rituximab 141pembrolizumab 140Nivolumab 126Oxaliplatin 124Dexamethasone 122Fluorouracil 113fludarabine 104Radiosurgery 101Doxorubicin 99fludarabine phosphate 97Irinotecan 96Etoposide 95Lenalidomide 93Cytarabine 92Magnetic Resonance Spectroscopy 90Radiation 89Filgrastim 89Leucovorin 88Bortezomib 86Cetuximab 80Pemetrexed 79

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × OTHER × Drug Evaluation × Clear all
NCT02032784 2020-07-16

Prophylactic Octreotide to Prevent Post Duodenal EMR and Ampullectomy Bleeding

AdventHealth

Phase 4 Terminated
33 enrolled

Adenoma

NCT02538471 2019-12-09

LY2157299 Monohydrate (LY2157299) and Radiotherapy in Metastatic Breast Cancer

Weill Medical College of Cornell University

Phase 2 Terminated
3 enrolled 11 charts
Breast

Breast Neoplasms

NCT01893879 2017-05-18

PCTTPL

Stanford University

Phase NA Terminated
14 enrolled 5 charts

Lymphedema

Data powered by HemOnc (CC BY 4.0) Colophon âš¡